GW PHARMACEUTICALS PLC Interest Expense
GW PHARMACEUTICALS PLC reported Interest Expense of $286.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2021-05-03
- GW PHARMACEUTICALS PLC interest expense for the quarter ending 2021-03-31 was $286.00K, a 0.70% increase year-over-year.
- GW PHARMACEUTICALS PLC interest expense for the quarter ending 2020-12-31 was $271.00K, a 3.90% decline year-over-year.
- GW PHARMACEUTICALS PLC interest expense for the quarter ending 2020-09-30 was $269.00K, a 1.10% decline year-over-year.
- GW PHARMACEUTICALS PLC interest expense for the quarter ending 2020-06-30 was $297.00K, a 10.82% increase year-over-year.
- GW PHARMACEUTICALS PLC interest expense for fiscal 2020 was $1.12M, a 3.13% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC interest expense for fiscal 2019 was $1.09M.
- GW PHARMACEUTICALS PLC interest expense for fiscal 2018 was $1.25M, a 31.34% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC interest expense for fiscal 2017 was $951.00K, a 289.75% increase from fiscal 2016.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2021-03-31 | $286.00K 10-Q · filed 2021-05-03 | $557.00K derived: sum of 2 quarters · filed 2021-05-03 | $826.00K derived: sum of 3 quarters · filed 2021-05-03 | $1.12M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $540.00K derived: sum of 2 quarters · filed 2021-02-26 | $837.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.12M 10-K · filed 2021-02-26 |
| 2020-09-30 | $269.00K 10-Q · filed 2020-11-05 | $566.00K derived: sum of 2 quarters · filed 2020-11-05 | $850.00K 10-Q · filed 2020-11-05 | $1.13M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $297.00K 10-Q · filed 2020-08-07 | $581.00K 10-Q · filed 2020-08-07 | $863.00K derived: sum of 3 quarters · filed 2021-05-03 | $1.14M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $284.00K 10-Q · filed 2021-05-03 | $566.00K derived: sum of 2 quarters · filed 2021-05-03 | $838.00K derived: sum of 3 quarters · filed 2021-05-03 | $1.11M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $554.00K derived: sum of 2 quarters · filed 2021-02-26 | $822.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.09M 10-K · filed 2021-02-26 |
| 2019-09-30 | $272.00K 10-Q · filed 2020-11-05 | $540.00K derived: sum of 2 quarters · filed 2020-11-05 | $805.00K 10-Q · filed 2020-11-05 | $1.10M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $268.00K 10-Q · filed 2020-08-07 | $533.00K 10-Q · filed 2020-08-07 | $828.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.13M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $265.00K 10-Q · filed 2020-05-11 | $560.00K derived: sum of 2 quarters · filed 2021-02-26 | $857.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.17M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $295.00K 10-K · filed 2021-02-26 | $592.00K derived: sum of 2 quarters · filed 2021-02-26 | $905.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.23M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $297.00K 10-Q · filed 2019-11-06 | $610.00K derived: sum of 2 quarters · filed 2019-11-06 | $935.00K 10-Q · filed 2019-11-06 | $1.25M 10-K · filed 2021-02-26 |
| 2018-06-30 | $313.00K 10-Q · filed 2019-08-07 | $638.00K 10-Q · filed 2019-08-07 | $952.00K derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | $325.00K 10-Q · filed 2019-05-08 | $639.00K derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | $314.00K 10-K · filed 2021-02-26 | |||
| 2017-09-30 | $951.00K 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $244.00K 10-KT · filed 2019-02-28 |